JPH0279990A - Production of phosphatidylserine - Google Patents
Production of phosphatidylserineInfo
- Publication number
- JPH0279990A JPH0279990A JP22978388A JP22978388A JPH0279990A JP H0279990 A JPH0279990 A JP H0279990A JP 22978388 A JP22978388 A JP 22978388A JP 22978388 A JP22978388 A JP 22978388A JP H0279990 A JPH0279990 A JP H0279990A
- Authority
- JP
- Japan
- Prior art keywords
- phosphatidylserine
- phospholipase
- streptomyces
- phosphatidylcholine
- serine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 title claims abstract description 34
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 title claims abstract description 32
- 238000004519 manufacturing process Methods 0.000 title claims description 7
- 102000011420 Phospholipase D Human genes 0.000 claims abstract description 22
- 108090000553 Phospholipase D Proteins 0.000 claims abstract description 22
- 241000187747 Streptomyces Species 0.000 claims abstract description 19
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 claims abstract description 15
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims abstract description 13
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims abstract description 11
- 244000005700 microbiome Species 0.000 claims abstract description 8
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 abstract description 15
- 238000006243 chemical reaction Methods 0.000 abstract description 12
- 238000000034 method Methods 0.000 abstract description 9
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 abstract description 8
- 239000001110 calcium chloride Substances 0.000 abstract description 8
- 229910001628 calcium chloride Inorganic materials 0.000 abstract description 8
- 230000000694 effects Effects 0.000 abstract description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract description 4
- 239000007864 aqueous solution Substances 0.000 abstract description 2
- 239000000243 solution Substances 0.000 abstract description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 abstract 2
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 abstract 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 abstract 1
- 239000007853 buffer solution Substances 0.000 abstract 1
- 238000004090 dissolution Methods 0.000 abstract 1
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 229960001153 serine Drugs 0.000 description 9
- 150000003904 phospholipids Chemical class 0.000 description 8
- 238000003786 synthesis reaction Methods 0.000 description 7
- 240000007124 Brassica oleracea Species 0.000 description 6
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 6
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 6
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 6
- 239000000194 fatty acid Substances 0.000 description 6
- 229930195729 fatty acid Natural products 0.000 description 6
- 150000004665 fatty acids Chemical class 0.000 description 6
- 239000008363 phosphate buffer Substances 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- KLFKZIQAIPDJCW-HTIIIDOHSA-N Dipalmitoylphosphatidylserine Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCC KLFKZIQAIPDJCW-HTIIIDOHSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 239000008351 acetate buffer Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 235000020138 yakult Nutrition 0.000 description 3
- KILNVBDSWZSGLL-KXQOOQHDSA-N 1,2-dihexadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC KILNVBDSWZSGLL-KXQOOQHDSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- MTCFGRXMJLQNBG-UWTATZPHSA-N D-Serine Chemical compound OC[C@@H](N)C(O)=O MTCFGRXMJLQNBG-UWTATZPHSA-N 0.000 description 2
- 229930195711 D-Serine Natural products 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical group C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 150000003905 phosphatidylinositols Chemical class 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- -1 silyl phosphatidylcholine Chemical compound 0.000 description 2
- ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
- 102000015439 Phospholipases Human genes 0.000 description 1
- 108010064785 Phospholipases Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 241000936729 Streptomyces hachijoensis Species 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000007910 cell fusion Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 229940068998 egg yolk phospholipid Drugs 0.000 description 1
- 239000008344 egg yolk phospholipid Substances 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
- 150000008106 phosphatidylserines Chemical class 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 1
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は、新しいホスファチジルセリンの製造方法に関
する。DETAILED DESCRIPTION OF THE INVENTION (Industrial Field of Application) The present invention relates to a new method for producing phosphatidylserine.
(従来の技術)
リン脂質は細胞の生体膜の成分として存在しており、生
体膜では二分子構造を持った二重層膜を形成し、タンパ
ク賞、コレステロール等とともに物質の透過、選択的輸
送等の生命現象に欠くことのできない機能を果たしてい
る。生体中にはホスファチジルコリン、ホスファチジル
エタノールアミン、ホスファチジルセリン、ホスファチ
ジルイノシトール、スフィンゴミエリン等のリン脂質が
存在し、各々重要な役割を果たしている。これらのリン
脂質に共通した特徴は、親水基と疎水基をその分子内に
持つことであり、これによりリン脂質に特徴的なリポソ
ームと呼ばれる微小胞を作ることができ、そこに薬剤を
含有させてドラッグデリバリ−システムへの展開がはか
られている。また一方ではそのものの生理活性作用を利
用して、PAFを代表するような医薬的展開もはかられ
ている。(Conventional technology) Phospholipids exist as components of biological membranes of cells, and in biological membranes, they form a double layer membrane with a bimolecular structure, and are used for the permeation of substances, selective transport, etc. along with proteins, cholesterol, etc. fulfills functions essential to life phenomena. Phospholipids such as phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, phosphatidylinositol, and sphingomyelin exist in living organisms, and each plays an important role. A common feature of these phospholipids is that they have a hydrophilic group and a hydrophobic group within their molecules, which allows them to create microvesicles called liposomes, which are characteristic of phospholipids, and drugs can be contained therein. Development of this technology into drug delivery systems is being planned. On the other hand, medical developments such as those typical of PAF are also being developed by utilizing its physiologically active effects.
ホスファチジルセリンは生物界には広く分布するが、量
的にはそれ程多くない、しかしながら細胞外液にホスフ
ァチジルセリンを加えておくと、ヒスタミンの遊離が増
強される等の生理活性作用や遺伝子工学分野での細胞融
合に用いられる等の用途が知られている。Although phosphatidylserine is widely distributed in the living world, its quantity is not very large.However, when phosphatidylserine is added to extracellular fluid, it has physiologically active effects such as enhancing the release of histamine, and has been used in the field of genetic engineering. It is known for its uses such as being used for cell fusion.
ホスファチジルセリンの製造は、従来、植物や動物の組
織より抽出後、精製分離されるのが一般的であるが、大
腸菌を用いて合成する方法(Ishinagaら、Eu
r、 J、 Biochem、+ 42+ 483(1
974))あるいはキャベツのホスホリパーゼDによる
合成(Yangら、J、 Biol、 Chew、、
242.477(1967))等の酵素的方法が知られ
ている。また化学的合成方法も知られている(Baer
ら、J、 Biol。Conventionally, phosphatidylserine has been produced by extracting it from plant or animal tissues and then purifying it.
r, J, Biochem, +42+483(1
974)) or synthesis by cabbage phospholipase D (Yang et al., J. Biol. Chew.
242.477 (1967)) are known. Chemical synthesis methods are also known (Baer
et al., J. Biol.
CheIll、 212 39 (1955)、Dee
nenら、Rec、 Trav。Chell, 212 39 (1955), Dee
nen et al., Rec, Trav.
Chim、 83.99 (1964) 、Turne
rら、J、 Lipid Res。Chim, 83.99 (1964), Turne
r et al., J. Lipid Res.
工、 616 (1964)など)。Engineering, 616 (1964), etc.).
(発明が解決しようとする課題)
前記動植物よりホスファチジルセリンを抽出する方法で
は、すでに述べたようにホスファチジルセリンの量的割
合が少ないこと、およびリン脂質の種類が多いことなど
から、精製分離が非常に困難である。それに加えて、結
合脂肪酸の種類が自由に選べず、多数の脂肪酸種の混じ
り合ったホスファチジルセリンしか得られないという問
題点がある。(Problems to be Solved by the Invention) In the method of extracting phosphatidylserine from animals and plants, as mentioned above, the quantitative ratio of phosphatidylserine is small and there are many types of phospholipids, so purification and separation is extremely difficult. It is difficult to In addition, there is a problem in that the type of bound fatty acid cannot be freely selected, and only phosphatidylserine that is a mixture of many fatty acid types can be obtained.
また大腸望やキャベツのホスホリパーゼDを用いて酵素
的にリン脂質の塩基交換や合成を行う方法は優れた方法
であるが、従来知られているこのような酵素は塩基交換
能が低いという問題点かある。Furthermore, enzymatic base exchange and synthesis of phospholipids using phospholipase D from large intestine and cabbage is an excellent method, but the problem is that conventionally known enzymes have low base exchange ability. There is.
化学合成法は大量に作ることができ、必要な脂肪酸のつ
いたホスファチジルセリンを合成できるという特徴を持
っているが、反応プロセスが非常に長く、しかもセリン
に反応性があるため、保護基の脱着といったプロセスも
加わり、工業的に非常に困難であるという問題がある。The chemical synthesis method has the advantage of being able to produce large quantities of phosphatidylserine with the necessary fatty acids attached, but the reaction process is very long and serine is reactive, making it difficult to remove the protective group. The problem is that this process is extremely difficult industrially.
この発明は、以上のような問題点を解決するためのもの
で、特定微生物起源のホスホリパーゼDにより、ホスフ
ァチジルコリンとセリンを反応させてホスファチジルセ
リンを得るものであり、高収率で塩基交換ができ、かつ
簡単な工程および装置でホスファチジルセリンを製造す
る方法を提供することを目的としている。This invention is intended to solve the above-mentioned problems, and is to obtain phosphatidylserine by reacting phosphatidylcholine and serine using phospholipase D derived from a specific microorganism. Another object of the present invention is to provide a method for producing phosphatidylserine using simple steps and equipment.
(課題を解決するための手段)
この発明は、ストレプトマイセス属の微生物を起源とす
るホスホリパーゼDを用いて、ホスファチジルコリンと
セリンを反応させることを特徴とするホスファチジルセ
リンの製造方法である。(Means for Solving the Problems) The present invention is a method for producing phosphatidylserine, which is characterized by reacting phosphatidylcholine and serine using phospholipase D originating from a microorganism of the genus Streptomyces.
すなわち、ホスファチジルコリンのコリン基をセリン基
と、ストレプトマイセス属微生物起源のホスホリパーゼ
Dにより、交換させることを特徴とする。That is, it is characterized in that the choline group of phosphatidylcholine is exchanged with a serine group by phospholipase D originating from a microorganism of the genus Streptomyces.
本発明に用いられるホスファチジルコリンは天然型の混
合脂肪酸型、合成型の1.2位確定脂肪酸型であり、酵
素反応であるため、不飽和度の高い脂肪酸を含むホスフ
ァチジルコリンも容易に用いることができる。The phosphatidylcholine used in the present invention is a natural mixed fatty acid type or a synthetic 1.2-position defined fatty acid type, and since it is an enzymatic reaction, phosphatidylcholine containing highly unsaturated fatty acids can also be easily used.
ホスファチジルセリンはホスファチジルコリンの構造に
従ったものを得ることができる。Phosphatidylserine can be obtained according to the structure of phosphatidylcholine.
もう一方の原料であるセリンはL体、0体とも用いるこ
とができ、本発明で用いられるストレプトマイセス属微
生物起源のホスホリパーゼDはホスファチジルセリンの
立体異性体の合成も可能である。ホスホリパーゼDは従
来よりホウレン草、キャベツ、ニンジン等から抽出され
、研究されてきているが、一般にその活性を発現させる
ためにはCa”が必要であるとされている。また、その
反応はエーテル、ケトン、エステル類により促進され、
ドデシル硫酸、ホスファチジン酸、ホスファチジルイノ
シトールによっても促進される。反対に、陽イオン界面
活性剤、コリン、エタノールアミン等は阻害的に働く。The other raw material, serine, can be used in either the L-form or the 0-form, and the phospholipase D derived from a microorganism of the genus Streptomyces used in the present invention can also synthesize stereoisomers of phosphatidylserine. Phospholipase D has been extracted from spinach, cabbage, carrots, etc. and has been studied, but it is generally believed that Ca' is required to express its activity. , promoted by esters,
It is also promoted by dodecyl sulfate, phosphatidic acid, and phosphatidylinositol. On the contrary, cationic surfactants, choline, ethanolamine, etc. act in an inhibitory manner.
ホスホリパーゼDは本発明においては塩基交換反応に用
いられるが、下式のように加水分解活性も持っている。Although phospholipase D is used in the base exchange reaction in the present invention, it also has hydrolytic activity as shown in the following formula.
それ故加水分解作用を少なくし、合成反応側に反応を進
める技゛術も重要である。即ち、反応に用いられるホス
ホリパーゼDが低加水分解性であることが重要である。Therefore, it is also important to have a technique to reduce the hydrolysis effect and advance the reaction toward the synthesis reaction side. That is, it is important that the phospholipase D used in the reaction has low hydrolyzability.
O−
(ホスファチジルセリン)
(ホスファチジン酸)
本発明で用いられるホスホリパーゼDは低加水分解性の
特徴を有しており、反応時に用いられる水の量により、
その加水分解性はほとんど影響を受けず、塩基交換反応
が優先的に進行し、特にホスファチジルセリンの合成に
は最適なものであり、放線菌目、特にストレプトマイセ
ス属菌より特異的に生産される。ストレプトマイセス属
菌としては、例えばストレプトマイセス・クロモフォラ
カス、ストレプトマイセス・プルニコーラ、ストレプト
マイセス・キサンスポリア、ストレプトマイセス・クロ
モジエニア、ストレプトマイセス・ハチジョーエンシス
、ストレプトマイセス・ベルティシジュムシナノニウム
等がある。O- (phosphatidylserine) (phosphatidic acid) Phospholipase D used in the present invention is characterized by low hydrolysis, and depending on the amount of water used during the reaction,
Its hydrolyzability is hardly affected, and the base exchange reaction proceeds preferentially, making it particularly suitable for the synthesis of phosphatidylserine, which is specifically produced by Streptomyces, especially Streptomyces. Ru. Streptomyces genus bacteria include, for example, Streptomyces chromophoracus, Streptomyces prunicola, Streptomyces xansporia, Streptomyces chromodienia, Streptomyces hachijoensis, and Streptomyces verticidumcinano. There are things like nium.
本発明に用いるホスホリパーゼDは市販品が利用できる
。Commercially available phospholipase D is available for use in the present invention.
本発明におけるホスファチジルセリン合成反応は具体的
には次のようにして行なう。Specifically, the phosphatidylserine synthesis reaction in the present invention is carried out as follows.
すなわち、攪拌装置および温度コントロール装置を有し
た反応装置で酢酸バッファーまたはリン酸バッファー水
溶液(約0.2 M、 pHは酵素種により異なるがp
H5〜7が適当である)に塩化カルシウム(0,01〜
0.2 M) 、ホスホリパーゼD(酵素活性力により
その必要量は異なるが、0.1ユニツト以上あれば反応
は可能である。ユニット数は30℃で1分間に生成する
ホスファチジン酸のマイクロモル数)およびセリン(濃
度が高い方が好ましく、基本的には飽和濃度(約5M)
がホスファチジルセリン生成の最大速度を与える)を所
定量加え、溶解させる。That is, in a reaction apparatus equipped with a stirring device and a temperature control device, an acetate buffer or phosphate buffer aqueous solution (approximately 0.2 M, pH varies depending on the enzyme type, but the p
Calcium chloride (H5-7 is suitable) and calcium chloride (0.01-7
0.2 M), phospholipase D (the required amount varies depending on the enzyme activity, but the reaction is possible if it is 0.1 unit or more. The number of units is the number of micromoles of phosphatidic acid produced in 1 minute at 30°C) ) and serine (higher concentration is preferable, basically saturation concentration (approximately 5M)
gives the maximum rate of phosphatidylserine production) and dissolve.
次いでホスファチジルコリンを酢酸エチル、エーテルな
どに溶解させて所定量(セリン/ホスファチジルコリン
比が大きい程、基本的には反応性が高い)を加え、25
〜35℃に保ち、1〜5時間攪拌して反応させる。反応
生成物はフォルチ法でクロロホルム層に抽出し、シリカ
ゲルカラムでクロロホルム・メタノール系溶出剤によっ
て精製分離する。Next, dissolve phosphatidylcholine in ethyl acetate, ether, etc., add a predetermined amount (the larger the serine/phosphatidylcholine ratio, the higher the reactivity), and add 25
Keep at ~35°C and stir for 1-5 hours to react. The reaction product is extracted into a chloroform layer using the Folch method, and purified and separated using a silica gel column using a chloroform/methanol-based eluent.
以上の工程を行うことにより、高純度のホスファチジル
セリンを所望の脂肪酸種を持って製造することができる
。By performing the above steps, highly pure phosphatidylserine having desired fatty acid species can be produced.
(発明の効果)
本発明によれば、ホスファチジルコリンとセリンをスト
レプトマイセス属微生物起源のホスホリパーゼDにより
、加水分解反応をほとんどおこさずに塩基交換反応する
ことができるので、安全で簡単な工程により、高収率で
ホスファチジルセリンを製造することができる。(Effects of the Invention) According to the present invention, phosphatidylcholine and serine can be subjected to a base exchange reaction using phospholipase D originating from a microorganism belonging to the genus Streptomyces without causing almost any hydrolysis reaction. Phosphatidylserine can be produced in high yield.
(実施例) 以下、実施例により本発明をさらに具体的に説明する。(Example) Hereinafter, the present invention will be explained in more detail with reference to Examples.
実施例1
0.2Mのリン酸バッファー10−に塩化カルシウム6
0■およびストレプトマイセス属由来のホスホリパーゼ
D(ヤクルト製) 10mg(0,1ユニツト)および
4.18のし一セリンを溶解させ30℃に保った。Example 1 Calcium chloride 6 in 0.2M phosphate buffer 10
10 mg (0.1 unit) of phospholipase D derived from the genus Streptomyces (manufactured by Yakult) and 4.18 grams of monoserine were dissolved and kept at 30°C.
次いで、やはり30℃に保って、20−の酢酸エチルに
溶解した卵黄リン脂質より精製したホスファチジルコリ
ン600■を加え、30℃で撹拌下、pH7で2時間反
応した。Next, while maintaining the temperature at 30 DEG C., 600 µm of phosphatidylcholine purified from egg yolk phospholipid dissolved in 20-degree ethyl acetate was added, and the mixture was reacted at 30 DEG C. with stirring at pH 7 for 2 hours.
反応液を分液ロートにとり、2:1のクロロホルムとメ
タノール500−と水180dを加え、クロロホルム層
を濃縮し、リン脂! 530mgを得た。これを展開剤
:クロロホルム/メタノール/酢酸15%NaHSOz
=40/15/6/2を用い、イヤトロスキャンで分析
したところ95.2%のホスファチジルセリンを含有し
ていた。このホスファチジルセリンをシリカゲルカラム
(クロロホルム/メタノール/水= 65/25/4)
で精製し、420IIwの純粋ホスファチジルセリンを
得た。Transfer the reaction solution to a separatory funnel, add 2:1 of chloroform, 500 g of methanol and 180 g of water, concentrate the chloroform layer, and remove phosphorus! 530 mg was obtained. Add this to developing agent: chloroform/methanol/acetic acid 15% NaHSOz
=40/15/6/2, and was analyzed by Iatroscan and found to contain 95.2% phosphatidylserine. This phosphatidylserine was transferred to a silica gel column (chloroform/methanol/water = 65/25/4).
420 IIw of pure phosphatidylserine was obtained.
実施例2
0.2Mの酢酸バッファー10−に塩化カルシウム60
ff1rおよびストレプトマイセス属由来のホスホリパ
ーゼD(東洋醗造製) 20mg(0,2ユニツト)お
よび2.05 gのし一セリンを溶解させ30℃に保っ
た。Example 2 Calcium chloride 60 to 0.2M acetate buffer 10
20 mg (0.2 units) of ff1r and Streptomyces-derived phospholipase D (manufactured by Toyo Brewery) and 2.05 g of shiichiserine were dissolved and kept at 30°C.
次いで、やはり30℃に保って、20−の酢酸エチルに
溶解したジパルミトイルホスファチジルコリン600■
を加え、30℃で攪拌下、pH5,6で4時間反応した
。Then, also kept at 30°C, 600 μl of dipalmitoylphosphatidylcholine dissolved in 20% ethyl acetate was added.
was added, and the mixture was reacted at 30° C. with stirring at pH 5, 6 for 4 hours.
実施例1と同様に処理し、93.3%の純度をもつジパ
ルミトイルホスファチジルセリン510■を得た。実施
例1と同様に精製し、純ジパルミトイルホスファチジル
セリン400mrを得た。The same procedure as in Example 1 was carried out to obtain 510 ml of dipalmitoyl phosphatidylserine having a purity of 93.3%. Purification was carried out in the same manner as in Example 1 to obtain 400 mr of pure dipalmitoylphosphatidylserine.
実施例3
0.2Mのリン酸バッファー10−に塩化カルシウム6
0■およびストレプトマイセス属由来のホスホリパーゼ
D(ヤクルト製)10■(0,1ユニツト)および5.
3gのD−セリンを溶解させ、実施例1と同様に反応さ
せ処理した。その結果、92.9%の純度をもつホスフ
ァチジルセリン520■を得、シリヵゲJl/ $#製
後後430■純り−セリン型ホスファチジルセリンを得
た。Example 3 Calcium chloride 6 in 0.2M phosphate buffer 10
0■ and Streptomyces-derived phospholipase D (manufactured by Yakult) 10■ (0.1 units) and 5.
3 g of D-serine was dissolved and reacted and treated in the same manner as in Example 1. As a result, 520 µm of phosphatidylserine with a purity of 92.9% was obtained, and 430 µm of pure serine-type phosphatidylserine was obtained after silicage Jl/$# production.
実施例4
0.2Mのリン酸バッファー10−に塩化カルシウム6
0■およびストレプトマイセス属由来のホスホリパーゼ
D(ヤクルト製)20■(0,2ユニツト)および4.
18のし一セリンを溶解させ30℃に保った。Example 4 Calcium chloride 6 in 0.2M phosphate buffer 10
0■ and Streptomyces-derived phospholipase D (manufactured by Yakult) 20■ (0.2 units) and 4.
No. 18 Serine was dissolved and kept at 30°C.
次いでやはり30℃に保って、20dの酢酸エチルに溶
解したシリルイルホスファチジルコリン1.2gを加え
、30℃でNt雰囲気下、pH1で4時間反応させた。Next, 1.2 g of silyl phosphatidylcholine dissolved in 20 d of ethyl acetate was added while keeping the temperature at 30° C., and the mixture was reacted at 30° C. under an Nt atmosphere at pH 1 for 4 hours.
実施例1と同様に処理し、82.2%の純度をもつシリ
ルイルホスファチジルセリン1.03gを得た。It was treated in the same manner as in Example 1 to obtain 1.03 g of silyl phosphatidylserine with a purity of 82.2%.
実施例1と同様に精製し、純シリルイルホスファチジル
セリン740■を得た。Purification was carried out in the same manner as in Example 1 to obtain 740 ml of pure silylylphosphatidylserine.
実施例5
0.2Mのリン酸バッファー50−を用い、実施例1と
同様に反応、精製し、93.8%のホスファチジルセリ
ンを含有したリン脂質510■を得た。実施例1と同様
に精製し、純ホスファチジルセリン410■を得た。Example 5 Using 0.2M phosphate buffer 50-1, the reaction and purification were carried out in the same manner as in Example 1, to obtain 510 ml of phospholipid containing 93.8% phosphatidylserine. Purification was carried out in the same manner as in Example 1 to obtain 410 ml of pure phosphatidylserine.
比較例1
キャベツ約3 kgをジューサーで処理し、遠心分離後
、上滑を50℃で5分間処置し、その後lO℃に急冷し
、再遠心分離した。上清に一20℃に冷却したアセトン
を2倍容量加え、沈澱を析出させた。Comparative Example 1 About 3 kg of cabbage was processed with a juicer, and after centrifugation, the top layer was treated at 50° C. for 5 minutes, then rapidly cooled to 10° C., and centrifuged again. Twice the volume of acetone cooled to -20°C was added to the supernatant to precipitate.
沈澱を回収し、凍結乾燥して粗ホスホリパーゼDとした
。The precipitate was collected and lyophilized to obtain crude phospholipase D.
0.2Mの酢酸バッファー10m1に塩化カルシウム6
0■および上記キャベツ由来の粗ホスホリパーゼD50
■(0,8ユニツト)および4.1gのL−セリンを溶
解させ、ジパルミトイルホスファチジルコリン1.2g
を実施例2と同様に反応させ処理した。その結果、22
.3%の純度をもつ粗ジパルミトイルホスファチジルセ
リン430■を得た。ホスファチジルセリン以外のリン
脂質は74.9%のジパルミトイルホスファチジン酸と
2.8%の未反応ホスファチジルコリンであった。Calcium chloride 6 in 10ml 0.2M acetate buffer
0■ and the crude phospholipase D50 derived from the above cabbage
(0.8 units) and 4.1 g of L-serine were dissolved, and 1.2 g of dipalmitoylphosphatidylcholine was added.
were reacted and treated in the same manner as in Example 2. As a result, 22
.. 430 ml of crude dipalmitoylphosphatidylserine with a purity of 3% was obtained. The phospholipids other than phosphatidylserine were 74.9% dipalmitoylphosphatidic acid and 2.8% unreacted phosphatidylcholine.
比較例2
比較例1で得たキャベツホスホリパーゼDにより比較例
1と同様にD−セリンを反応させたがホスファチジルセ
リンは全く生成しなかった。Comparative Example 2 D-serine was reacted with cabbage phospholipase D obtained in Comparative Example 1 in the same manner as in Comparative Example 1, but no phosphatidylserine was produced.
Claims (1)
ホリパーゼDを用いて、ホスファチジルコリンとセリン
を反応させることを特徴とするホスファチジルセリンの
製造方法。(1) A method for producing phosphatidylserine, which comprises reacting phosphatidylcholine and serine using phospholipase D originating from a microorganism of the genus Streptomyces.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP22978388A JPH0279990A (en) | 1988-09-16 | 1988-09-16 | Production of phosphatidylserine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP22978388A JPH0279990A (en) | 1988-09-16 | 1988-09-16 | Production of phosphatidylserine |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH0279990A true JPH0279990A (en) | 1990-03-20 |
Family
ID=16897605
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP22978388A Pending JPH0279990A (en) | 1988-09-16 | 1988-09-16 | Production of phosphatidylserine |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0279990A (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997017460A1 (en) * | 1995-11-08 | 1997-05-15 | Kabushiki Kaisha Yakult Honsha | Process for producing phosphatidylserines having polybasic unsaturated fatty acid as side chain |
KR20030086128A (en) * | 2002-05-03 | 2003-11-07 | 주식회사 두산 | Method for producing phosphatidylserine and lysophosphatidylserine comprising recycling enzymes and serines |
KR100442538B1 (en) * | 2001-05-07 | 2004-07-30 | 주식회사 두산 | Method for producing phosphatidylserine and lysophosphatidylserine in organic solvent |
KR20040069438A (en) * | 2003-01-29 | 2004-08-06 | 주식회사 두산 | Method for producing modified lecithin using mixture of organic solvents |
KR100446399B1 (en) * | 1995-12-08 | 2004-11-12 | 이탈파르마코 수드 에스.피.아. | How to prepare phosphatidylserine |
EP1605056A2 (en) * | 2004-05-07 | 2005-12-14 | The Nisshin OilliO Group, Ltd. | Process for recovering serine |
CN103351403A (en) * | 2013-07-24 | 2013-10-16 | 华东师范大学 | Synthetic method of phosphatidylserine |
-
1988
- 1988-09-16 JP JP22978388A patent/JPH0279990A/en active Pending
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997017460A1 (en) * | 1995-11-08 | 1997-05-15 | Kabushiki Kaisha Yakult Honsha | Process for producing phosphatidylserines having polybasic unsaturated fatty acid as side chain |
US5965413A (en) * | 1995-11-08 | 1999-10-12 | Kabushiki Kaisha Yakult Honsha | Process for producing phosphatidylserines having long chain unsaturated fatty acid as side chain |
CN1103818C (en) * | 1995-11-08 | 2003-03-26 | 株式会社雅库路特本社 | Process for producing phosphatidylserines having polybasic unsaturated fatty acid and as side chain |
KR100446399B1 (en) * | 1995-12-08 | 2004-11-12 | 이탈파르마코 수드 에스.피.아. | How to prepare phosphatidylserine |
KR100442538B1 (en) * | 2001-05-07 | 2004-07-30 | 주식회사 두산 | Method for producing phosphatidylserine and lysophosphatidylserine in organic solvent |
KR20030086128A (en) * | 2002-05-03 | 2003-11-07 | 주식회사 두산 | Method for producing phosphatidylserine and lysophosphatidylserine comprising recycling enzymes and serines |
KR20040069438A (en) * | 2003-01-29 | 2004-08-06 | 주식회사 두산 | Method for producing modified lecithin using mixture of organic solvents |
EP1605056A2 (en) * | 2004-05-07 | 2005-12-14 | The Nisshin OilliO Group, Ltd. | Process for recovering serine |
EP1605056A3 (en) * | 2004-05-07 | 2005-12-21 | The Nisshin OilliO Group, Ltd. | Process for recovering serine |
CN103351403A (en) * | 2013-07-24 | 2013-10-16 | 华东师范大学 | Synthetic method of phosphatidylserine |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2206099T3 (en) | A PROCEDURE FOR THE PREPARATION OF FOSFATIDILSERINAS. | |
EP0776976B2 (en) | A process for the industrial preparation of phosphatidylserine | |
JPS59187792A (en) | Production of phospholipid saccharide derivative using enzymic method | |
US5183750A (en) | Processes for the production of phosphatidic acid | |
JP4045100B2 (en) | Method for producing lysophosphatidylethanolamine | |
Juneja et al. | Increasing productivity by removing choline in conversion of phosphatidylcholine to phosphatidylserine by phospholipase D | |
JPH0279990A (en) | Production of phosphatidylserine | |
JPH028717B2 (en) | ||
Nakajima et al. | A facile transphosphatidylation reaction using a culture supernatant of actinomycetes directly as a phospholipase D catalyst with a chelating agent | |
JPH0387191A (en) | Production of phosphatidylinositol | |
JP3697189B2 (en) | Phospholipid base exchange method | |
JPS6336792A (en) | Production of phospholipid by enzyme | |
Moyed et al. | Studies on the adenosine triphosphate-propionate reaction in extracts of an unidentified bacterium | |
JP2001178489A (en) | Method of producing cyclic phosphatidic acid | |
JPS63123389A (en) | Production of phospholipid-d-serine derivative by enzymatic method | |
JPH027633B2 (en) | ||
JP5526467B2 (en) | Method for producing ceramide | |
JPH028716B2 (en) | ||
JP2731852B2 (en) | A new method for producing lysophosphatidylcholine. | |
JP2683590B2 (en) | Method for producing enzyme-converted phospholipid | |
JPS6188886A (en) | Preparation of phospholipid long-chain alcohol derivative by enzymatic process | |
JPH0677509B2 (en) | Method for producing modified phospholipid | |
JPH0367675B2 (en) | ||
JPS63263089A (en) | Production of phospholipid | |
JP2000270857A (en) | Phospholipase d and its production |